glp 1 diabetes Mechanisms of action of GLP-1RA More people with type 1
Description
In contrast, the PD1 antagonist market forecasts a slower growth rate, projecting a 4.7 per cent CAGR and a market size of $51 billion in 2029, nearly half of the GLP1 agonist market
Growing private healthcare expenditure and increasing physician adoption of advanced metabolic therapies continue to support market expansion
Frias JP, Bastyr EJ 3rd, Vignati L, et al
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint
